《新股消息》云想科技(02131.HK)發售價定於6.98元 一手中籤率僅10%
云想科技(02131.HK)公布發售價及配發結果,發售價定於每股6.98元,稍高於招股價區間5.56元至7.08元之中位數,是次發行集資所得淨額為12.93億元。
按發售價計算,根據與基石投資者的基石投資協議,AHAM認購2,220.8萬股,匯豐環球投資管理(香港)及太平洋投資管理分別認購555.2萬股,小苗基金認購444.1萬股,Green Better認購333.1萬股,SensePower Management認購222萬股,合共4,330.4萬股。
股份公開發售部份獲114.45倍認購,經重新分配後,相關分部將佔整體發行股份50%,一手中籤率10%,抽25手穩獲一手。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.